Dorchester Minerals, L.p.
DMLP Nasdaq Crude Petroleum & Natural Gas Financials FY2016βFY2025
Last close Β· Oct 23, 2026
$30.64
2.2%What Dorchester Minerals, L.p. does
No business description yet.
- Legal name
- DORCHESTER MINERALS, L.P.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 24, 2026
- Accession Β· CIK
- 0001437749-26-005376
0001172358
Revenue and margins
Dorchester Minerals, L.p. had $153M of revenue in fiscal 2025, down 5.4% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Dorchester Minerals, L.p. returned β to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Dorchester Minerals, L.p. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $28.3M | $40.8M | $47.0M | $42.5M | $41.9M |
| Current ratio | 16.6x | 18.3x | 15.6x | 16.0x | 15.5x |
| Quick ratio | 16.6x | 18.3x | 15.6x | 16.0x | 15.5x |
| Total assets | $147M | $176M | $191M | $367M | $310M |
| Total liabilities | $4.4M | $4.7M | $5.5M | $5.0M | $4.3M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 5 / 7 | 7 / 7 | 3 / 7 | 3 / 7 | 6 / 7 | β / 6 | β / 6 | β / 6 | β / 6 |
| Accruals ratio | β10.9% | β7.0% | β9.6% | β13.0% | β17.1% | β0.1% | β10.2% | β14.0% | β14.4% | β22.2% |
| Altman Z'' | β | β | β | β | β | β | β | β | β | β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $37.6M | $57.3M | $73.3M | $78.8M | $46.9M | $93.4M | $171M | $164M | $162M | $153M |
| Operating income | $21.0M | β | β | β | β | β | β | β | β | β |
| Net income | $21.0M | $38.4M | $53.9M | $52.8M | $21.9M | $70.2M | $131M | $114M | $92.4M | $57.4M |
| Diluted EPS | $0.66 | $1.18 | $1.61 | $1.50 | $0.61 | $1.94 | β | β | β | β |
| Diluted shares | 0.03B | 0.03B | 0.00B | 0.03B | 0.03B | 0.04B | β | β | β | β |
| Cash flow | ||||||||||
| Cash from operations | $28.3M | $44.0M | $62.5M | $66.1M | $39.4M | $70.3M | $147M | $140M | $133M | $132M |
| Depreciation and amortization | $8.5M | $9.3M | $8.9M | $13.3M | $11.9M | $10.5M | $19.1M | $26.3M | $42.6M | $66.3M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $8.2M | $13.8M | $18.3M | $15.3M | $11.2M | $28.3M | $40.8M | $47.0M | $42.5M | $41.9M |
| Current assets | $14.8M | $25.4M | $30.1M | $28.3M | $18.2M | $46.7M | $62.5M | $69.7M | $67.8M | $58.9M |
| Current liabilities | $0.3M | $0.6M | $0.5M | $2.4M | $1.9M | $2.8M | $3.4M | $4.5M | $4.2M | $3.8M |
| Total assets | $67.2M | $92.0M | $87.9M | $117M | $88.3M | $147M | $176M | $191M | $367M | $310M |
| Total liabilities | $0.3M | $1.3M | $1.3M | $4.5M | $3.8M | $4.4M | $4.7M | $5.5M | $5.0M | $4.3M |
| Margins | ||||||||||
| Operating margin | 55.8% | β | β | β | β | β | β | β | β | β |
| EBITDA margin | 78.5% | β | β | β | β | β | β | β | β | β |
| Net margin | 55.8% | 67.1% | 73.6% | 67.0% | 46.6% | 75.1% | 76.5% | 69.7% | 57.2% | 37.5% |
| Returns | ||||||||||
| Return on capital employed | 31.3% | β | β | β | β | β | β | β | β | β |
| Return on assets | 31.2% | 48.3% | 59.9% | 51.5% | 21.3% | 59.7% | 80.9% | 62.1% | 33.1% | 17.0% |
| Growth | ||||||||||
| Revenue growth | β | 52.5% | 27.9% | 7.5% | β40.4% | 99.1% | 82.8% | β4.1% | β1.4% | β5.4% |
| Net income growth | β | 83.3% | 40.3% | β2.1% | β58.6% | 220.9% | 86.1% | β12.6% | β19.0% | β38.0% |
| EPS growth | β | 78.8% | 36.4% | β6.8% | β59.3% | 218.0% | β | β | β | β |
| Share count change | β | 2.7% | β99.9% | 105,553.3% | 1.6% | 1.1% | β | β | β | β |
| Financial health | ||||||||||
| Current ratio | 53.8x | 39.8x | 62.0x | 12.0x | 9.7x | 16.6x | 18.3x | 15.6x | 16.0x | 15.5x |
| Quick ratio | 53.8x | 39.8x | 62.0x | 12.0x | 9.7x | 16.6x | 18.3x | 15.6x | 16.0x | 15.5x |
| Quality scores | ||||||||||
| Piotroski F-score | β | 5.0 | 7.0 | 3.0 | 3.0 | 6.0 | β | β | β | β |
| Accruals ratio | β10.9% | β7.0% | β9.6% | β13.0% | β17.1% | β0.1% | β10.2% | β14.0% | β14.4% | β22.2% |
Source: SEC EDGAR XBRL filings (CIK 0001172358). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.